48.59
price down icon0.51%   -0.25
after-market Handel nachbörslich: 48.00 -0.59 -1.21%
loading

Ptc Therapeutics Inc Aktie (PTCT) Neueste Nachrichten

pulisher
Jun 18, 2025

10 Biotech Stocks Screaming a Buy - Insider Monkey

Jun 18, 2025
pulisher
Jun 17, 2025

PTC Therapeutics (PTCT): Truist Securities Initiates Coverage with 'Buy' Rating | PTCT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc.PTCT - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Truist Financial Initiates Coverage on PTC Therapeutics (NASDAQ:PTCT) - MarketBeat

Jun 17, 2025
pulisher
Jun 17, 2025

PTC Therapeutics (PTCT) Gains Buy Rating with Promising Drug Pipeline | PTCT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

PTCT Investors Have Opportunity to Join PTC Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

When the Price of (PTCT) Talks, People Listen - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 16, 2025

GAMMA Investing LLC Increases Stake in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jun 16, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Purchases New Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Harbor Capital Advisors Inc. Sells 11,891 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jun 15, 2025
pulisher
Jun 14, 2025

PTC Therapeutics’ SWOT analysis: biotech stock’s potential in rare disease market - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 14, 2025

PTC Therapeutics’ SWOT analysis: biotech stock’s potential in rare disease market By Investing.com - Investing.com South Africa

Jun 14, 2025
pulisher
Jun 14, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) Stake Lowered by Assenagon Asset Management S.A. - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc.PTCT - Eastern Progress

Jun 13, 2025
pulisher
Jun 13, 2025

Cantor Fitzgerald Weighs in on PTCT FY2026 Earnings - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

Phenylktonuria Pipeline 2025: Therapies, MOA Insights, and Key - openPR.com

Jun 12, 2025
pulisher
Jun 12, 2025

Phenylktonuria Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Erytech Pharma SA, Homology Medicines Inc., Synlogic Inc., BioMarin Pharmaceuticals - Barchart.com

Jun 12, 2025
pulisher
Jun 11, 2025

uniQure Prepares for Historic Huntington's Disease Treatment Launch with Key Executive Hire - Stock Titan

Jun 11, 2025
pulisher
Jun 10, 2025

Encephalopathy Pipeline 2025: Comprehensive Clinical Trials - openPR.com

Jun 10, 2025
pulisher
Jun 10, 2025

PTC Therapeutics at Goldman Sachs Conference: Strategic Growth Insights By Investing.com - Investing.com UK

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : PTC Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 09 - marketscreener.com

Jun 10, 2025
pulisher
Jun 09, 2025

Friedreich's Ataxia Market Set to Witness Rare Disease Drug - openPR.com

Jun 09, 2025
pulisher
Jun 09, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) Stake Lessened by Public Employees Retirement System of Ohio - MarketBeat

Jun 09, 2025
pulisher
Jun 09, 2025

William Blair Issues Pessimistic Estimate for PTCT Earnings - MarketBeat

Jun 09, 2025
pulisher
Jun 07, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PTC Therapeutics, Inc. (PTCT) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 07, 2025

William Blair Predicts Lower Earnings for PTC Therapeutics - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

All You Need to Know About PTC Therapeutics (PTCT) Rating Upgrade to Buy - sharewise

Jun 06, 2025
pulisher
Jun 06, 2025

Roche gets EU nod for Evrysdi's expanded label in spinal muscular atrophy - MSN

Jun 06, 2025
pulisher
Jun 05, 2025

Universal Beteiligungs und Servicegesellschaft mbH Purchases Shares of 108,345 PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jun 05, 2025
pulisher
Jun 05, 2025

Friedreich's Ataxia Market Poised for Rapid Expansion During the Forecast Period (2025-2034) as Drug Pipeline Gains Momentum | DelveInsight - Yahoo Finance

Jun 05, 2025
pulisher
Jun 05, 2025

PTC Therapeutics: Strong Buy Rating Backed by Promising Sepiapterin Launch and Robust Financial Outlook - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 26,274 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jun 05, 2025
pulisher
Jun 04, 2025

Mackenzie Financial Corp Boosts Stock Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

Ameriprise Financial Inc. Has $1.94 Million Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

PTC Therapeutics (PTCT) Price Target Raised by RBC Capital | PTCT Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

RBC Capital raises PTC Therapeutics stock price target to $60 By Investing.com - Investing.com India

Jun 04, 2025
pulisher
Jun 04, 2025

RBC Raises Price Target on PTC Therapeutics to $60 From $58, Keeps Outperform Rating - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Trend Tracker for (PTCT) - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 03, 2025

PTC Therapeutics at William Blair Conference: Strategic Growth and Innovation - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

Huntington’s Disease Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics | DelveInsight - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

PTC Therapeutics : William Blair 45th Annual Growth Stock Conference Presentation - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Deepening digitalization in drug discovery at PTC therapeutics - SelectScience

Jun 03, 2025
pulisher
Jun 02, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - GlobeNewswire Inc.

Jun 02, 2025
pulisher
Jun 02, 2025

RBC Capital maintains outperform rating for PTC Therapeutics stock By Investing.com - Investing.com Nigeria

Jun 02, 2025
pulisher
Jun 02, 2025

Citi maintains neutral rating on PTC Therapeutics stock - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

PTCT Benefits from FDA's Flexible Approach to Huntington's Disea - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Universal Beteiligungs und Servicegesellschaft mbH Takes Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jun 02, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Kapitalisierung:     |  Volumen (24h):